Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Fossati, G, Nesbitt, A
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2010
Pynciau:
Poster Presentation
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3007781/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-8-S1-P37
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg